Progression-directed Therapy for Oligoprogression in Castration-refractory Prostate Cancer

Berghen, C; Joniau, S; Ost, P; Poels, K; Everaerts, W; Decaestecker, K; Haustermans, K; Devos, G; De Meerleer, G

Berghen, C (corresponding author), Univ Hosp Leuven, Herestr 49, B-3000 Leuven, Belgium.

EUROPEAN UROLOGY ONCOLOGY, 2021; 4 (2): 305

Abstract

In metastatic castration-refractory prostate cancer (mCRPC), state-of-the-art treatment consists of androgen biosynthesis inhibition (abiraterone), in......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索